Nonketotic hyperglycemic coma
Hyperosmolar diabetic coma (HNDC) is a rare, severe acute complication of diabetes, which is more common in elderly patients with no history of diabetes or mild non-insulin-dependent diabetes, but can also be seen in patients with insulin-dependent diabetes. The patient's original insulin secretion is insufficient, and the blood sugar rises rapidly under the influence of inducements, which promotes the aggravation of sugar metabolism disorders, causing the extracellular fluid to be hyperosmotic, hypovolemic hyperosmotic dehydration, and the original arteriosclerosis causing insufficient blood supply and hypoxia in the cerebral cortex, resulting in mental and neurological symptoms and coma.
-
Site of disease:
Brain Pancreas -
Infectious :
Not contagious -
Frequent population:
Elderly people, those with decreased renal function -
Related symptoms:
Polydipsia polyuria drowsiness thirst and polydipsia breath may smell like rotten apples -
Concurrent disease:
Related Drugs
Gliclazide Tablets
Indication: Used for type 2 diabetes.
Manufacturer:
Harbin Pharmaceutical Group Co., Ltd. GENERAL Pharm. FACTORY
Thirst-quenching and blood sugar-lowering capsules
Manufacturer:
Beijing Tongrentang Co., Ltd. Tongrentang Pharmaceutical Factory
nateglinide tablets
Indication: This product can be used alone for patients with type 2 diabetes who cannot effectively control hyperglycemia through diet and exercise, or for patients with type 2 diabetes who cannot effectively control hyperglycemia with metformin. It is used in combination with metformin, but it cannot replace metformin. Nateglinide is not suitable for patients with type 2 diabetes who are not ideal for treatment with sulfonylurea hypoglycemic drugs.
Manufacturer:
Guangzhou Baiyunshan ZHONGYI Pharmaceutical Company Limited
Meclofenoxate Hydrochloride Capsules
Indication: Traumatic coma, alcohol poisoning, neonatal hypoxia, and enuresis in children.
Manufacturer:
China Resources Zizhu Pharmaceutical Co., Ltd.
Pioglitazone Hydrochloride Tablets
Indication: Type 2 diabetes (or non-insulin-dependent diabetes mellitus, NIDDM).
Manufacturer:
Beijing Taiyang Pharmaceutical Industry Co., Ltd.
Rosiglitazone Sodium Tablets
Indication: 1. This product is only suitable for patients with type 2 diabetes who cannot achieve the blood sugar control target with other hypoglycemic drugs. 2. Taking this product alone, supplemented with diet control and exercise, can control the blood sugar of patients with type 2 diabetes. 3. For patients with type 2 diabetes who do not have good blood sugar control with diet control and exercise plus this product or a single anti-diabetic drug, this product can be used in combination with metformin or sulfonylurea drugs. For patients who take the maximum recommended dose of metformin or sulfonylurea drugs and have poor blood sugar control, this product cannot replace the original anti-diabetic drugs and needs to be used in combination with them. 4. Dietary control is one of the measures for the treatment of type 2 diabetes. Restricting calories, losing weight and increasing exercise can all help improve insulin sensitivity. Therefore, it is not only the basic treatment for type 2 diabetes, but also can be effective.
Jinqijiangtang Capsules
Manufacturer:
Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
Chlorpropamide Tablets
Indication: It is suitable for mild and moderate type Ⅱ diabetes mellitus that is not satisfactory with diet alone, and the patient's pancreatic β cells have a certain insulin secretion function and no serious complications. This product can also be used for central diabetes insipidus.
Manufacturer:
ORxes Biopharmaceuticals (Shenyang) Co., Ltd.
Glucomannan Capsules
Indication: It is used for habitual constipation, senile constipation, and can also be used to prevent and treat hyperlipidemia and diabetes.
Manufacturer:
Sichuan Kechuang Pharmaceutical Group Co., Ltd.
Related Ingredients
-
Gliclazide list
21187-98-4 -
Nateglinide list
105816-04-4 -
2-(Dimethylamino)ethyl (4-chlorphenoxy)acetate list
51-68-3 -
Pioglitazone hydrochloride list
112529-15-4 -
5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione sodium salt list
316371-83-2